Literature DB >> 15040893

Aberrant expression and function of TCF4 in the proliferation of hepatocellular carcinoma cell line BEL-7402.

Dong Hong Zhao1, Jian Jun Hong, Shi Ying Guo, Run Lin Yang, Jun Yuan, Chuan Yu Wen, Kai Ya Zhou, Chao Jun Li.   

Abstract

Wnt signaling pathway is essential for development and tumorigenesis, however, this signaling pathway in the progress of hepatocellular carcinoma (HCC) remains unclear. In this paper, we studied the function of human T-cell transcription factor-4 (TCF4), a key factor of Wnt signaling pathway, on the proliferation of HCC cell line. We showed that the expression of TCF4 mRNA in HCC cell line BEL-7402 was higher than that in immortalized normal liver cell line L02. Blockage of Wnt pathway by Delta-NTCF4, a dominant negative TCF4, could suppress BEL-7402 cells growth and decrease the expression of cyclin D1 and c-myc, two of target genes of Wnt pathway. On the other hand, stimulating Wnt pathway by introducing a degradation-resistant -catenin S37A could increase BEL-7402 cells proliferation. But all the treatments had no effect on L02 cells. Our data indicated that TCF4 might be another key factor in Wnt pathway involved in HCC cells proliferation and TCF4 could be an effective therapeutic target for suppressing the growth of hepatocellular cancers.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15040893     DOI: 10.1038/sj.cr.7290205

Source DB:  PubMed          Journal:  Cell Res        ISSN: 1001-0602            Impact factor:   25.617


  12 in total

1.  Wnt-pathway activation in two molecular classes of hepatocellular carcinoma and experimental modulation by sorafenib.

Authors:  Anja Lachenmayer; Clara Alsinet; Radoslav Savic; Laia Cabellos; Sara Toffanin; Yujin Hoshida; Augusto Villanueva; Beatriz Minguez; Philippa Newell; Hung-Wen Tsai; Jordi Barretina; Swan Thung; Stephen C Ward; Jordi Bruix; Vincenzo Mazzaferro; Myron Schwartz; Scott L Friedman; Josep M Llovet
Journal:  Clin Cancer Res       Date:  2012-07-18       Impact factor: 12.531

2.  Signatures of plasticity, metastasis, and immunosuppression in an atlas of human small cell lung cancer.

Authors:  Joseph M Chan; Álvaro Quintanal-Villalonga; Vianne Ran Gao; Yubin Xie; Viola Allaj; Ojasvi Chaudhary; Ignas Masilionis; Jacklynn Egger; Andrew Chow; Thomas Walle; Marissa Mattar; Dig V K Yarlagadda; James L Wang; Fathema Uddin; Michael Offin; Metamia Ciampricotti; Besnik Qeriqi; Amber Bahr; Elisa de Stanchina; Umesh K Bhanot; W Victoria Lai; Matthew J Bott; David R Jones; Arvin Ruiz; Marina K Baine; Yanyun Li; Natasha Rekhtman; John T Poirier; Tal Nawy; Triparna Sen; Linas Mazutis; Travis J Hollmann; Dana Pe'er; Charles M Rudin
Journal:  Cancer Cell       Date:  2021-10-14       Impact factor: 31.743

3.  Gene regulation is governed by a core network in hepatocellular carcinoma.

Authors:  Zuguang Gu; Chenyu Zhang; Jin Wang
Journal:  BMC Syst Biol       Date:  2012-05-01

4.  Transcription factor E2-2 inhibits the proliferation of endothelial progenitor cells by suppressing autophagy.

Authors:  Li Zhang; Yang Yu; Xi Xia; Yang Ma; Xie-Wan Chen; Zhen-Hong Ni; Hong Wang
Journal:  Int J Mol Med       Date:  2016-03-09       Impact factor: 4.101

5.  Association of transcription factor 7-like 2 gene polymorphisms with breast cancer risk in northwest Chinese women.

Authors:  Weili Min; Xinghan Liu; Ye Lu; Zhuoqing Gong; Meng Wang; Shuai Lin; Huafeng Kang; Tianbo Jin; Xijing Wang; Xiaobin Ma; Kang Liu; Cong Dai; Yi Zheng; Shanli Li; Qingyong Ma; Zhijun Dai
Journal:  Oncotarget       Date:  2016-11-22

6.  miR-133a-5p suppresses gastric cancer through TCF4 down-regulation.

Authors:  Mu-Qun He; Jian-Feng Wan; Hong-Fu Zeng; Ying-Yan Tang; Mu-Qing He
Journal:  J Gastrointest Oncol       Date:  2021-06

7.  miR-23b regulates cytoskeletal remodeling, motility and metastasis by directly targeting multiple transcripts.

Authors:  Loredana Pellegrino; Justin Stebbing; Vania M Braga; Adam E Frampton; Jimmy Jacob; Lakjaya Buluwela; Long R Jiao; Manikandan Periyasamy; Chris D Madsen; Matthew P Caley; Silvia Ottaviani; Laura Roca-Alonso; Mona El-Bahrawy; R Charles Coombes; Jonathan Krell; Leandro Castellano
Journal:  Nucleic Acids Res       Date:  2013-04-10       Impact factor: 16.971

Review 8.  Aberrant regulation of Wnt signaling in hepatocellular carcinoma.

Authors:  Li-Juan Liu; Shui-Xiang Xie; Ya-Tang Chen; Jing-Ling Xue; Chuan-Jie Zhang; Fan Zhu
Journal:  World J Gastroenterol       Date:  2016-09-07       Impact factor: 5.742

9.  A pilot systematic genomic comparison of recurrence risks of hepatitis B virus-associated hepatocellular carcinoma with low- and high-degree liver fibrosis.

Authors:  Seungyeul Yoo; Wenhui Wang; Qin Wang; M Isabel Fiel; Eunjee Lee; Spiros P Hiotis; Jun Zhu
Journal:  BMC Med       Date:  2017-12-07       Impact factor: 8.775

10.  Super-enhancer-driven AJUBA is activated by TCF4 and involved in epithelial-mesenchymal transition in the progression of Hepatocellular Carcinoma.

Authors:  Chi Zhang; Shi Wei; Wei-Peng Sun; Kai Teng; Miao-Miao Dai; Feng-Wei Wang; Jie-Wei Chen; Han Ling; Xiao-Dan Ma; Zi-Hao Feng; Jin-Ling Duan; Mu-Yan Cai; Dan Xie
Journal:  Theranostics       Date:  2020-07-11       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.